wayground logo

Free Printable Worksheets

Font size

S
M
L
XL
Worksheets

Cerebris Pre ENHANCE Quiz (Dec FY25-26)

Total questions: 19

Worksheet time: 25mins

Name
Class
Date
1.

Your region Name :

4 lines
2.

Your Emp Code is

4 lines
3.

AGPTOY contains - Agmatine Sulphate 500 mg __________, _____ and ________. (Tick 3 correct options)

a)

Palmitoylethanolamide (PEA) 300 mg

b)

Palmitoylethanolamide (PEA) 500 mg

c)

Uridine Monophosphate (UMP) 1.5 mg

d)

Cytidine Monophosphate (CMP) 2.5 mg

e)

Cytidine Monophosphate (CMP) 1.5 mg

4.

Which of the following is a common cause of neuropathic pain?

a)

Diabetes

b)

Hypertension

c)

Asthma

d)

Allergies

5.

Tagline of brand - AGPTOY is __________

a)

" Call to confidence"

b)

"Effectively Innovative"

c)

"Innovatively Effective"

d)

"Qualitatively Innovative"

6.

Dosage for AGPTOY _____________ post food intake followed by 1 Tab OD for 6 Months

a)

1 Tab OD for 4 – 6 months post food intake followed by 1 Tab OD for 6 Months

b)

1 Tab BID for 1 month post food intake followed by 1 Tab OD for 6 Months

c)

1 Tab BID for 4 – 6 months post food intake followed by 1 Tab OD for 6 Months

d)

1 Capsule BID for 4 – 6 months post food intake followed by 1 Cap OD for 6 Months

7.

Agmatine sulphate mode of action includes................

a)

NMDA Receptor Modulation

b)

Inhibition of Nitric Oxide (NO) Production

c)

Alpha-2 Adrenergic Receptor Activation

d)

Opioid System Analgesic action (Endocannabinoid System)

e)

NMDA Receptor activation

8.

______________PEA ensures maximum absorption, prolonged action, and superior pain relief as early as 1 week. (Fill in the blank)

a)

Biological

b)

Bio-similar

c)

Bio-Optimized

d)

Bio-Equivalent

9.

We are pleased to present to you the ___ Issue of our scientific publication in collaboration with Neurology Today.

This edition features _____curated, high-impact articles that provide valuable insights into the latest advancements and clinical perspectives in the field of neurology. (As per DEC'25 Input)

a)

10th Issue, 9 curated

b)

10th Issue, 15 curated

c)

12th Issue, 15 curated

d)

12th Issue, 20 curated

10.

As per Ecitelo VA communication " Ecitelo - Escitalopram has superior efficacy over other SSRIs - ____% higher effectiveness"

a)

86

b)

10

c)

100

d)

12

11.

•Studies suggest Levetiracetam is more ____ than Brivaracetam in achieving seizure freedom — giving your patients a better chance. (as per VA)

a)

economical

b)

reliable

c)

dependable

12.

Mention your Cerebris - Priorities - actionable for 2025-26 (Minimum 3 actionables)

4 lines
13.

To disseminate scientific knowledge and promote critical thinking skills among young Drs and PG students. We have initiated a monthly initiative named as __________

a)

NCC (Neurology Clinical Conundrum)

b)

NESSAN e-EEG Course

c)

Neuro-360 HMS Course

d)

2 min EME

e)

Neurology Today Updates

14.

Epifast RTU with LEV is safe option in Post Stroke seizures as compared to ___________ thus offers confidence in emergency care (as per VA communication)

a)

CBZ (Carbamazepine) & OXC (Oxcarbazapine)

b)

PHY (Phenytoin) & VPA (Valproate)

c)

BRV (Brivaracetam) & OXC (Oxcarbazapine)

d)

BRV (Brivaracetam) & CBZ (carbamazapine)

15.

Swasth365 is 1st ever comprehensive and personalized Disease Management Program providing_____________(Tick all those which are applicable)

a)

Doctor Follow-up Support

b)

Lifestyle & Psychologist Support:

c)

Pill Reminder Services

d)

Prescription Refill Assistance

e)

Gym fitness support

16.

Solopose with Etizolam has clinically proven efficacy and safety as Etizolam has ______ times more potency than that of ___________ (Fill in the blanks in sequesce)

a)

5 - 6 times , Lorazepam

b)

2 - 3 times , Diazapam

c)

6 - 10 times , Diazapam

d)

6 - 10 times , Alprazolam

17.

Prebris MNT - Pregabalin offers ______% reduction at 12 weeks

a)

12.6 %

b)

60.6 %

c)

86 %

d)

88.6 %

18.

USFDA approved and recommended as first line therapy for Small Fibre Neuropathy. (Identify the brand)

a)

AGPTOY

b)

DUXEAD

c)

TRUGABA

d)

PREBRIS MNT

19.

Inhibition of Nitric Oxide (NO) Production – helps decrease __________

a)

sensation

b)

nerve inflammation.

c)

nerve repair

d)

nerve regeneration